Clearmind Medicine Looks to Move Forward with its Novel Psychedelic MEAI- Based Alcohol Substitute
Clearmind Medicine receives IRB approval for Phase I/IIa clinical trial of CMND-100 [Seeking Alpha]
Clearmind Medicine Receives IRB Approval for its FDA-Regulated Clinical Trial [Yahoo! Finance]
Clearmind Medicine Receives IRB Approval for its FDA-Regulated Clinical Trial
Clearmind Medicine and Dr Glitter Pty Ltd Sign Term Sheet for Mutual Development of Novel Psychedelic MEAI- Based Alcohol Substitute in ActivCrystal™ Format